ID   ASB2_RAT                Reviewed;         634 AA.
AC   Q5U2S6;
DT   02-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 1.
DT   29-MAY-2024, entry version 138.
DE   RecName: Full=Ankyrin repeat and SOCS box protein 2;
DE            Short=ASB-2;
GN   Name=Asb2 {ECO:0000312|EMBL:AAH85882.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Brown Norway; TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Substrate-recognition component of a SCF-like ECS (Elongin-
CC       Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which
CC       mediates the ubiquitination and subsequent proteasomal degradation of
CC       target proteins (By similarity). Mediates Notch-induced ubiquitination
CC       and degradation of substrates including E2A and JAK2 (By similarity).
CC       Required during embryonic heart development for complete heart looping
CC       (By similarity). Required for cardiomyocyte differentiation (By
CC       similarity). Involved in myogenic differentiation and targets filamin
CC       FLNB for proteasomal degradation but not filamin FLNA (By similarity).
CC       Also targets DES for proteasomal degradation (By similarity). Acts as a
CC       negative regulator of skeletal muscle mass (By similarity).
CC       {ECO:0000250|UniProtKB:Q8K0L0, ECO:0000250|UniProtKB:Q96Q27}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Component of a probable ECS E3 ubiquitin-protein ligase
CC       complex which contains CUL5, either RBX1 or RNF7/RBX2, Elongin BC
CC       complex (ELOB and ELOC) and ASB2. Interacts with SKP2. Through its
CC       interaction with SKP2, likely to bridge the formation of dimeric E3-
CC       ubiquitin-protein ligase complexes composed of an ECS complex and an
CC       SCF(SKP2) complex. Interacts with JAK2; the interaction targets JAK2
CC       for Notch-mediated proteasomal degradation. Interacts with TCF3/E2A;
CC       the interaction is mediated by SKP2 and targets TCF3 for Notch-mediated
CC       proteasomal degradation (By similarity). Interacts with DES (By
CC       similarity). {ECO:0000250|UniProtKB:Q8K0L0,
CC       ECO:0000250|UniProtKB:Q96Q27}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, stress fiber
CC       {ECO:0000250|UniProtKB:Q96Q27}. Cytoplasm, myofibril, sarcomere, Z line
CC       {ECO:0000250|UniProtKB:Q8K0L0}. Note=Localizes to the Z line in
CC       cardiomyocytes. {ECO:0000250|UniProtKB:Q8K0L0}.
CC   -!- DOMAIN: The SOCS box domain mediates the interaction with the Elongin
CC       BC complex, an adapter module in different E3 ubiquitin-protein ligase
CC       complexes. {ECO:0000250|UniProtKB:Q96Q27}.
CC   -!- DOMAIN: The UIM domain is required for monoubiquitination.
CC       {ECO:0000250|UniProtKB:Q96Q27}.
CC   -!- PTM: Monoubiquitinated. {ECO:0000250|UniProtKB:Q96Q27}.
CC   -!- SIMILARITY: Belongs to the ankyrin SOCS box (ASB) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC085882; AAH85882.1; -; mRNA.
DR   RefSeq; NP_001011984.1; NM_001011984.1.
DR   AlphaFoldDB; Q5U2S6; -.
DR   SMR; Q5U2S6; -.
DR   CORUM; Q5U2S6; -.
DR   STRING; 10116.ENSRNOP00000071182; -.
DR   PhosphoSitePlus; Q5U2S6; -.
DR   PaxDb; 10116-ENSRNOP00000012045; -.
DR   Ensembl; ENSRNOT00000085517.2; ENSRNOP00000071182.1; ENSRNOG00000051619.2.
DR   GeneID; 299266; -.
DR   KEGG; rno:299266; -.
DR   UCSC; RGD:1306414; rat.
DR   AGR; RGD:1306414; -.
DR   CTD; 51676; -.
DR   RGD; 1306414; Asb2.
DR   eggNOG; KOG0504; Eukaryota.
DR   GeneTree; ENSGT00940000155490; -.
DR   HOGENOM; CLU_023739_2_0_1; -.
DR   InParanoid; Q5U2S6; -.
DR   OMA; WTCIKEK; -.
DR   OrthoDB; 5474869at2759; -.
DR   PhylomeDB; Q5U2S6; -.
DR   TreeFam; TF315127; -.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:Q5U2S6; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000051619; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   GO; GO:0001725; C:stress fiber; IEA:UniProtKB-SubCell.
DR   GO; GO:0000151; C:ubiquitin ligase complex; ISO:RGD.
DR   GO; GO:0030018; C:Z disc; ISO:RGD.
DR   GO; GO:0097602; F:cullin family protein binding; ISO:RGD.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:Ensembl.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0055013; P:cardiac muscle cell development; ISS:UniProtKB.
DR   GO; GO:0055007; P:cardiac muscle cell differentiation; ISS:UniProtKB.
DR   GO; GO:0036336; P:dendritic cell migration; ISO:RGD.
DR   GO; GO:0001947; P:heart looping; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0071800; P:podosome assembly; ISO:RGD.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; ISO:RGD.
DR   GO; GO:0014732; P:skeletal muscle atrophy; ISS:UniProtKB.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; ISO:RGD.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISO:RGD.
DR   CDD; cd03721; SOCS_ASB2; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 3.
DR   Gene3D; 1.10.750.20; SOCS box; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR037330; ASB2_SOCS.
DR   InterPro; IPR001496; SOCS_box.
DR   InterPro; IPR036036; SOCS_box-like_dom_sf.
DR   PANTHER; PTHR24178; MOLTING PROTEIN MLT-4; 1.
DR   Pfam; PF12796; Ank_2; 3.
DR   Pfam; PF13606; Ank_3; 1.
DR   Pfam; PF13637; Ank_4; 1.
DR   Pfam; PF07525; SOCS_box; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 11.
DR   SMART; SM00253; SOCS; 1.
DR   SMART; SM00969; SOCS_box; 1.
DR   SUPFAM; SSF48403; Ankyrin repeat; 2.
DR   SUPFAM; SSF158235; SOCS box-like; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 8.
DR   PROSITE; PS50225; SOCS; 1.
PE   2: Evidence at transcript level;
KW   ANK repeat; Cytoplasm; Cytoskeleton; Phosphoprotein; Reference proteome;
KW   Repeat; Ubl conjugation; Ubl conjugation pathway.
FT   CHAIN           1..634
FT                   /note="Ankyrin repeat and SOCS box protein 2"
FT                   /id="PRO_0000233304"
FT   DOMAIN          26..45
FT                   /note="UIM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00213"
FT   REPEAT          104..133
FT                   /note="ANK 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          137..167
FT                   /note="ANK 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          171..200
FT                   /note="ANK 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          204..233
FT                   /note="ANK 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          237..266
FT                   /note="ANK 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          270..299
FT                   /note="ANK 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          303..332
FT                   /note="ANK 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          336..365
FT                   /note="ANK 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          368..397
FT                   /note="ANK 9"
FT                   /evidence="ECO:0000255"
FT   REPEAT          410..439
FT                   /note="ANK 10"
FT                   /evidence="ECO:0000255"
FT   REPEAT          440..469
FT                   /note="ANK 11"
FT                   /evidence="ECO:0000255"
FT   REPEAT          476..504
FT                   /note="ANK 12"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          580..634
FT                   /note="SOCS box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00194"
FT   REGION          35..81
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        44..70
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         371
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96Q27"
SQ   SEQUENCE   634 AA;  70205 MW;  CB4E89389609C199 CRC64;
     MSTEISTRGR QRAIGHEEYS LYSSLSEEEL VQMAIEQSLA DKTRGPTPAE TSVSSQTNHQ
     PGHIHPWTRS SSPPESPPAR APLGLFQGVM QKYSSNLFKT SQMAAMDPVL KAIKEGDEEA
     LKAMIQDGKN LAEPNKEGWL PLHEAAYYGK LGCLKVLQRA YPGTIDQRTL QEETALYLAT
     CREHLDCLLS LLQAGAEPDI SNKSRETPLY KACERKNAEA VRILVQYNAD ANHRCNRGWT
     ALHESVSRND LEVMEILVSG GAKVEAKNVY SITPLFVAAQ SGQLEALRFL AKHGADINTQ
     ASDSASALYE ACKNEHEDVV EFLLSQGADA NKANKDGLLP LHVASKKGNY RIVQMLLPVT
     SRTRVRRSGI SPLHLAAERN HDAVLEALLA ARFDVNTPLA PERARLYEDR RTSALYFAVV
     NNNVYATELL LLAGADPNRD VISPLLVAIR HGCLRTMQLL LDHGANIDAY IATHPTAFPA
     TIMFAMKCLS LLKFLMDLGC DGEPCFSCLY GNGPHPPAPR SGRFNDAPVD DKAPSVVQFC
     EFLSAPEVSR WAGPIIDVLL DYVGNVQLCS RLKEHIDSFE DWAVIKEKAE PPRPLAHLCR
     LRVRKAIGKY RIKLLDTLPL PGRLIRYLKY ENTQ
//
